Main menu

Pages

Hot News

PIJR - PARIPEX Indian Journal of Research

PIJR - PARIPEX  Indian Journal of Research


Title: PARIPEX - Indian Journal of Research (PIJR)
ISSN: 2250-1991
Web: www.worldwidejournals.com/paripex/

PIJR - PARIPEX  Indian Journal of Research

PIJR - PARIPEX  Indian Journal of ResearchPARIPEX - Indian Journal of Research (PIJR) is a double reviewed monthly print journal that accepts research works from scholars, academicians, professors, doctorates, lecturers, and corporate in their respective expertise of studies. Work after publication will be retrievable on the website bifurcated based on issues of the month and its publication date. Moreover, the journal serves the research world since January, 2012.
The journal is wide and available for diverse intellectual and educational pursuit from all corners of the society to enrich the learning experience of the group readers.

PARIPEX - Indian Journal of Research applies a double blind peer review. Referees remain anonymous for the author during the review procedure and the authors name is removed from the manuscript under review.
Only after publication, and only with the permission of the referee, the names of the reviewers are published in the article.
Each article is first assessed by two of the editors of the editorial board and, if it is judged suitable for PIJR, it is sent to two or three external referees for a double blind peer review. PIJR uses three different review forms (Research and Theory, Integrated Care Cases, Policy papers) all of which apply scientific criteria and take account of the purpose of the article and its merits for integrated care.

Based on the recommendations of the reviewers, the editors then decide whether the paper should be accepted as is, revised or rejected. In case of revisions, a final decision on publication will be made after resubmission. If there is no agreement on the part of the editors, the editor-in-chief will make the final decision.

Indexing

PIJR - PARIPEX  Indian Journal of Research

reactions

Comments

3 comments
Post a Comment
  1. I WOULD LIKE TO UNDERSTAND WHETHER YOU ACCEPT PHARMA REALTED TOPICS OR RESEARCH.

    ReplyDelete
  2. It nice to get information that PERIPEX in going to enter to SCOPUS Index, Congrates to editor.

    ReplyDelete

Post a Comment

SHARE YOUR VIEW,
POST A COMMENT

table of contents title